1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Immune Markers Are Associated with Cognitive Performance in a Multiethnic Cohort: the Northern Manhattan Study, 2021, Elkind,Hornig et al

Discussion in 'Other health news and research' started by Sly Saint, Jul 26, 2021.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,588
    Location:
    UK
    Highlights

    Immune molecules associate with cognition in an ethnically diverse population.


    They add information about cognition beyond traditional risk factors like age and vascular risk.


    Chemokines CCL11 and CXCL9, the neurotrophic factor HGF, and serpin E1 most consistently associated with global cognition, as well as individual cognitive domains.


    These data provide potential immune pathways as targets to reduce cognitive decline.

    Abstract
    Objective
    To determine whether immune protein panels add significant information to correlates of cognition.

    Background
    Immune mechanisms in vascular cognitive aging are incompletely characterized.

    DESIGN/METHODS: A subsample of the prospective Northern Manhattan Study underwent detailed neuropsychological testing. Cognitive scores were converted into Z-scores and categorized into four domains (memory, language, processing speed, and executive function) based on factor analysis. Blood samples were analyzed using a 60-plex immunoassay. We used least absolute shrinkage and selection operator (LASSO) procedures to select markers and their interactions independently associated with cognitive scores. Linear regression models assessed cross-sectional associations of known correlates of cognition with cognitive scores, and assessed model fit before and after addition of LASSO-selected immune markers.

    Results
    Among 1179 participants (mean age 70±8.9 years, 60% women, 68% Hispanic), inclusion of LASSO-selected immune markers improved model fit above age, education, and other risk factors (p for likelihood ratio test<0.005 for all domains). C-C Motif Chemokine Ligand 11 (CCL 11, eotaxin), C-X-C Motif Chemokine Ligand 9 (CXCL9), hepatocyte growth factor (HGF), and serpin E1 (plasminogen activator inhibitor-1) were associated with each of the domains and with overall cognitive function. Immune marker effects were comparable to conventional risk factors: for executive function, each standard deviation (SD) increase in CCL11 was associated with an effect equivalent to aging three years; for memory, HGF had twice the effect of aging.

    Conclusions
    Immune markers associate with cognitive function in a multi-ethnic cohort. Further work is needed to validate these findings and determine optimal treatment targets.

    https://www.sciencedirect.com/science/article/abs/pii/S0889159121002750
     
  2. duncan

    duncan Senior Member (Voting Rights)

    Messages:
    1,607
    I wonder if VEGF is considered an immune marker, and if they looked at that seeing as how low VEGF values can be, I think, associated with cognitive decline.
     
    Last edited: Jul 26, 2021
    Peter Trewhitt likes this.

Share This Page